Barclays PLC Schedule 13G passive stakes

Barclays PLC has filed an amended Schedule 13G, reporting a beneficial ownership of 7.58% of Texas Ventures Acquisition-A's common stock.

Barclays PLC has reported a 7.45% beneficial ownership stake in NMP Acquisition Corp A, holding 904,720 common shares as of September 30, 2025.

Barclays PLC has reported a beneficial ownership of 7.41% in Thayer Ventures Acquisition Corp. Class A common stock, holding 1,519,375 shares.

Barclays PLC has reported a beneficial ownership of 7.32% in Dune Acquisition Corp II, holding over 1 million common shares.

Barclays PLC has filed an amended Schedule 13G, disclosing a 7.13% beneficial ownership stake in Live Oak Acquisition Corp-A common stock as of September 30, 2025.

Barclays PLC has reported a 5.32% beneficial ownership stake in Zentalis Pharmaceuticals Inc., totaling 3,841,449 common shares.

Barclays PLC has reported a 5.27% beneficial ownership stake in Axiom Intelligence-CL A, holding over 1 million common shares.

Barclays PLC has reported a beneficial ownership of 5.27% in Core Scientific Inc., holding over 16 million common shares.

Barclays PLC has reported a 5.24% beneficial ownership stake in FG MERGER II CORP, holding 540,000 shares of common stock.

Barclays PLC has reported a beneficial ownership of 5.24% of WEN ACQUISITION CORP-A's common stock, totaling 1,573,202 shares.

Barclays PLC has reported a 5.23% beneficial ownership stake in Cumulus Media Inc. Class A common stock, held in the ordinary course of business.

Barclays PLC has reported a 5.2% beneficial ownership stake in Shenandoah Telecommunication, holding 2,857,490 common shares.

Barclays PLC has reported a 5.11% beneficial ownership stake in CAL REDWOOD ACQUISIT-CL A, totaling 1,209,200 common shares.

Barclays PLC has disclosed a beneficial ownership of 5.01% in Vine Hill Capital's Class A Common Stock, holding sole voting and dispositive power over the shares.

Barclays PLC has reported a 4.23% beneficial ownership stake in Myriad Genetics Inc. common stock as of September 30, 2025.

Barclays PLC has reported a 1.95% beneficial ownership stake in Ironwood Pharmaceuticals Inc., holding 3,167,713 common shares.

Barclays PLC has reported an 8.00% beneficial ownership stake in IB ACQUISITION CORP, holding 459,219 common shares as of September 30, 2025.

Barclays PLC has increased its beneficial ownership in Sizzle Acquisition Corp-CL A to 6.90%, holding 1,629,026 common shares.

Barclays PLC has filed an amended Schedule 13G, reporting a 6.80% beneficial ownership stake in Jackson Acquisition Co-CL A common stock.

Barclays PLC has disclosed a 6.82% beneficial ownership stake in Everspin Technologies Inc., holding 1,544,267 common shares as of September 30, 2025.

Barclays PLC has reported a passive 5.62% ownership stake in MarketWise Inc., holding 148,961 common shares.

Barclays PLC has disclosed a beneficial ownership of 5.67% of Sizzle Acquisition Corp.'s Common Stock, totaling 1,339,026 shares.

Barclays PLC has disclosed a 5.71% beneficial ownership stake in Criteo SA-Sponsored ADRs, totaling 3,035,479 shares, as of June 30, 2025.

Barclays PLC has disclosed a 5.77% beneficial ownership stake in Madison Square Garden Entertainment Corp. through a Schedule 13G filing.

Barclays PLC has disclosed a passive beneficial ownership of 5.78% in Mobileye Global Inc.'s common stock, totaling 5,811,249 shares.

Barclays PLC has disclosed a 5.81% beneficial ownership stake in StealthGas Inc., holding over 2.15 million common shares.

Barclays PLC has filed an amended Schedule 13G, disclosing a 5.83% beneficial ownership stake in Kelly Services Inc. Class A common stock.

Barclays PLC has disclosed a 5.99% passive ownership stake in Cantor Equity Partners-CL A, holding 1,472,517 common shares.

Barclays PLC has reported a beneficial ownership of 6.13% in Thayer Ventures Acquisition's UNIT securities, totaling 1,257,646 shares.

Barclays PLC has disclosed a 6.30% beneficial ownership stake in Archimedes Tech SPAC Partner's common stock as of June 30, 2025.